Volume 7, Issue 26 (4-2017)                   NCMBJ 2017, 7(26): 19-26 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jafari Sales A, Mobaiyen H. Frequency and resistance patterns in clinical isolates of Escherichia coli Extended Spectrum Beta Lactamase producing treatment Centers in Marand city, Iran. NCMBJ 2017; 7 (26) :19-26
URL: http://ncmbjpiau.ir/article-1-946-en.html
Young Researchers and Elite Club, Ahar Branch, Islamic Azad University, Ahar, Iran , A.jafari_1392@yahoo.com
Abstract:   (7707 Views)
Aim and Background: The production of Extended Spectrum Beta Lactamases (ESBLs) by Escherichia coli is the main cause of resistance to Cephalosporins , Worldwide has tremendously increased. The aim of this study was to determine the prevalence of ESBL-producing E. coli and antibiotic resistance patterns of those. Materials and Methods: In this study, 196 cases of E. coli within 6 months from patients referring to the public and private treatment centers Marand city were collected and identified by biochemical tests. ESBL screening and confirmation along with antimicrobial susceptibility test was done according to the Clinical Laboratory Standards Institute (CLSI) guidelines. Results: Of 196 isolates, 100 isolates (51.02%) were produced ESBL. 82% of the isolates were resistant to Ampicillin and 76% of the isolates were Sensitive to Imipenem. Conclusions: Organisms expressing ESBLs in this study were widely distributed, often possessing the multidrug resistance phenotype. Limiting the use of broad-spectrum Cephalosporins is recommended to control this high rate of ESBL expression.
Full-Text [PDF 420 kb]   (2813 Downloads)    
Type of Study: Research Article | Subject: Genetics
Received: 2017/06/11 | Accepted: 2017/06/11 | Published: 2017/06/11

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb